The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
Official Title: Prospective Evaluation of Pelvic Exenteration in Patients With Recurrent Cervical Cancer
Study ID: NCT00217633
Brief Summary: This phase II trial is studying how well pelvic exenteration works in treating patients with recurrent cervical cancer. Pelvic exenteration may be effective in treating recurrent cervical cancer.
Detailed Description: PRIMARY OBJECTIVE: I. Correlate progression-free survival and overall survival with tumor size, time interval between primary cancer management and pelvic exenteration, and presence or absence of pelvic sidewall fixation by clinical examination in patients with recurrent cervical cancer treated with pelvic exenteration. SECONDARY OBJECTIVES: I. Determine quality of life of patients treated with this procedure. II. Correlate quality of life with reconstructive technique (e.g., no ostomy or ≥ 1 ostomy) in patients treated with this procedure. OUTLINE: Patients undergo pelvic exenteration within 14 days after study entry. Quality of life is assessed at baseline and at 6, 12, and 24 months after surgery. After completion of study treatment, patients are followed within 30 days, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Colorado Gynecologic Oncology Group, Aurora, Colorado, United States
Hartford Hospital, Hartford, Connecticut, United States
The Hospital of Central Connecticut, New Britain, Connecticut, United States
Beebe Medical Center, Lewes, Delaware, United States
Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States
Georgia Regents University Medical Center, Augusta, Georgia, United States
Memorial University Medical Center, Savannah, Georgia, United States
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
Union Hospital of Cecil County, Elkton MD, Maryland, United States
University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
The Cancer Institute of New Jersey Hamilton, Hamilton, New Jersey, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States
Lake University Ireland Cancer Center, Mentor, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Cancer Care Associates-Midtown, Tulsa, Oklahoma, United States
Tulsa Cancer Institute, Tulsa, Oklahoma, United States
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
M D Anderson Cancer Center, Houston, Texas, United States
Auburn Regional Medical Center, Auburn, Washington, United States
Providence Regional Cancer System-Centralia, Centralia, Washington, United States
Saint Francis Hospital, Federal Way, Washington, United States
Saint Clare Hospital, Lakewood, Washington, United States
Providence - Saint Peter Hospital, Olympia, Washington, United States
Capital Medical Center, Olympia, Washington, United States
MultiCare Good Samaritan Hospital, Puyallup, Washington, United States
MultiCare Allenmore Hospital, Tacoma, Washington, United States
MultiCare Tacoma General Hospital, Tacoma, Washington, United States
Northwest CCOP, Tacoma, Washington, United States
Saint Joseph Medical Center, Tacoma, Washington, United States
Multicare Health System, Tacoma, Washington, United States
M D Anderson International Spain, Madrid, , Spain
Name: D. McMeekin
Affiliation: Gynecologic Oncology Group
Role: PRINCIPAL_INVESTIGATOR